Wednesday, June 24, 2026

North Korea’s Key Figures Resurface: What Does This Mean for South-North Relations?

North Korea maintains key figures in inter-Korean dialogues despite tensions, suggesting a strategic shift in foreign relations.

South Korea’s Response to Trump’s Warship Request: What You Need to Know

South Korea's Foreign Minister addresses Trump's naval request for Hormuz; lawmakers call for cautious approach and parliamentary approval.

Flying Trash? North Korean Balloons Cause Stir at South Korea’s Presidential HQ!

South Korea's presidential office took urgent measures after discovering multiple waste balloons sent from North Korea within its premises.

Jin Joong Hwang

A New Era in Precision Oncology—Lunit Unveils 7 AI-Driven Cancer Studies at AACR 2025

Lunit will present AI biomarker studies at AACR 2025, focusing on rare cancers and improving treatment strategies using AI analysis.

FDA Ruling Paves Way for Pharmacy Substitution of Yuflyma for Humira

Celltrion's Yuflyma receives FDA approval for interchangeability with Humira, boosting market confidence and distribution in the U.S.

Sandoz: Millions of Patients Denied Access to Affordable Enbrel Alternative

Sandoz has filed an antitrust lawsuit against Amgen to challenge patent practices blocking its biosimilar, Erelzi, from market entry.

Europe Moves to Ease Biosimilar Rules, Boosting Asia’s Biopharma Giants

EMA's new guidelines aim to simplify biosimilar development, boosting Samsung Bioepis and Celltrion in Europe's growing market.

Long-Acting HIV Treatment Vocabria + Rekambys Offers New Hope with Just Six Injections a Year

Long-acting HIV treatment Vocabria + Rekambys improves adherence and quality of life, reducing daily pill burden to six injections yearly.

ProGen’s PG-110 Targets Fat Loss Without Muscle Waste—Next-Gen Obesity Drug in Focus

ProGen will present non-clinical results of its obesity drug PG-110 at the ADA conference, targeting muscle preservation and weight loss.

Top News

- Our Sponsors Ad -

Follow us